Page last updated: 2024-08-21

hematoxylin and Ureteral Obstruction

hematoxylin has been researched along with Ureteral Obstruction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, Z; Lu, S; Ren, T; Tian, L; Wang, Y; Zhang, T; Zhao, W1
Chen, Y; Cui, J; Nie, K; Wan, J; Weng, M; Wu, X; Yang, L; You, D1
Ben, Y; Chang, Y; Chen, G; Gao, X; Hao, J; Li, H; Ma, X; Qiang, P; Shimosawa, T; Wang, X; Xiong, Y; Xu, Q; Yang, F1

Other Studies

3 other study(ies) available for hematoxylin and Ureteral Obstruction

ArticleYear
Establishment of Mini-pig Model of Ureteral Stricture by Electrocoagulation Under Ureteroscopy.
    Urology, 2022, Volume: 167

    Topics: Animals; Constriction, Pathologic; Electrocoagulation; Eosine Yellowish-(YS); Female; Hematoxylin; Swine; Swine, Miniature; Ureter; Ureteral Calculi; Ureteral Obstruction; Ureteroscopy

2022
C3aR contributes to unilateral ureteral obstruction-induced renal interstitial fibrosis via the activation of the NLRP3 inflammasome.
    Life sciences, 2022, Nov-01, Volume: 308

    Topics: Animals; Complement C3a; Creatinine; DNA Nucleotidylexotransferase; Eosine Yellowish-(YS); Fibrosis; Hematoxylin; Inflammasomes; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Receptors, G-Protein-Coupled; Urea; Ureteral Obstruction

2022
Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2022, Volume: 2022

    Topics: Actins; Aldosterone; Animals; Collagen; Eosine Yellowish-(YS); Eplerenone; Fibrosis; Glucocorticoids; Hematoxylin; Interleukin-1beta; Kidney; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renal Insufficiency, Chronic; RNA, Messenger; Ureteral Obstruction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Ventricular Remodeling

2022